1. Ensuring Safety
1.1. Vaccine Safety Monitoring
1.1.1. Vaccine Adverse Event Reporting System (VAERS)
1.1.1.1. Summary of Adverse Events in Pregnant Women
1.1.1.2. VAERS Print and Web Material
1.1.1.3. VAERS Publications
1.1.2. Clinical Immunization Safety Assessment (CISA) Project
1.1.2.1. CISA Clinician Resources
1.1.2.2. CISA Evaluation
1.1.2.3. Current Studies
1.1.2.4. Historical Background 2001 - 2012
1.1.2.5. Publications
1.1.2.6. Technical Reports
1.1.3. Vaccine Safety Datalink
1.1.3.1. Accessing Data from VSD
1.1.3.2. Guidelines for VSD Data Sharing
1.1.3.3. Publications
1.1.4. Emergency Preparedness
1.1.4.1. Swine Flu
1.1.4.2. Smallpox
1.2. Archived Vaccine Safety Monitoring Activities
1.3. History of Vaccine Safety
1.3.1. History of Vaccine Safety (Archived)
1.4. Understanding Side Effects and Adverse Events
1.5. Vaccine Safety Partners
2. Information for Parents and Caregivers
2.1. FAQs about Vaccine Safety
3. Common Vaccine Safety Concerns
3.1. Adjuvants
3.2. Autism
3.2.1. CDC Statement: 2004 Pediatrics Paper
3.2.2. Vaccines Not Associated with Risk of Autism
3.3. Fainting (Syncope)
3.3.1. Syncope FAQs - Vaccine Safety
3.4. Childhood Vaccines and Febrile Seizures
3.4.1. Febrile Seizures / 2012-2013 Flu Season
3.4.2. Febrile Seizures / 2010-2011 Flu Season
3.5. Guillain-Barre Syndrome
3.6. Multiple Vaccines and the Immune System
3.7. Sudden Infant Death Syndrome (SIDS)
3.8. Thimerosal
3.8.1. FAQs about Thimerosal
3.8.2. Timeline: Thimerosal in Vaccines
3.8.3. CDC Study on Thimerosal and Risk of Autism
3.8.4. Infant and Environmental Exposures to Thimerosal
3.8.5. Publications
3.9. Vaccine Recalls
3.10. Vaccines During Pregnancy
3.11. Historical Vaccine Safety Concerns
3.11.1. FAQs about Hep B and Multiple Sclerosis
3.11.2. Narcolepsy Following Pandemrix Influenza Vaccination in Europe
3.11.3. FAQs about GBS and Menactra
3.11.3.1. GBS and Menactra
3.11.4. Hib Vaccine Recall Summary
3.11.5. Gardasil Vaccine Recall FAQ
4. Vaccine Safety Research
4.1. Vaccine Safety Publications
4.1.1. 2015
4.1.2. 2014
4.1.3. 2013
4.1.4. 2012
4.1.5. 2000 - 2011
4.2. ISO Scientific Agenda
4.2.1. ISO Scientific Agenda Archive
4.3. IOM Reports on Vaccine Safety
5. Information for Health Care Professionals
5.1. Reporting an Adverse Event
5.2. Talking to Patients About Vaccine Safety
5.3. Vaccine Safety Resources for Health Care Professionals
6. Safety Information About Specific Vaccines
6.1. Anthrax Vaccine
6.2. Chickenpox (Varicella) Vaccine
6.3. Diphtheria, Tetanus, and Acellular Pertussis Vaccines: DTaP, Td, and Tdap
6.4. Haemophilus Influenza Type b (Hib) Vaccine
6.5. Hepatitis A Vaccine
6.6. Hepatitis B Vaccine
6.7. Human Papillomavirus Vaccine
6.7.1. HPV Vaccine Safety FAQ
6.7.2. Summary of HPV Adverse Event Reports Published in JAMA
6.7.3. Archived Information from FDA and CDC on Gardasil Safety
6.8. Influenza Vaccine
6.9. Japanese Encephalitis Vaccine
6.10. Measles, Mumps and Rubella Vaccine
6.10.1. MMR Vaccine Safety Studies
6.11. Measles, Mumps, Rubella, and Varicella Vaccine
6.11.1. VSD MMRV Safety Study
6.11.2. MMRV Vaccine Safety Studies